ASCO-SITC Clinical Immuno-Oncology Symposium. San Francisco, California, USA - January 25-27, 2018
The American Society of Clinical Oncology–Society for Immunotherapy of Cancer (ASCO-SITC) Clinical Immuno-Oncology Symposium focused on clinical and translational research in immuno-oncology and the implications for clinical care. Specifically, speakers discussed immunotherapy in melanoma, lung cancer, genitourinary cancers, head and neck cancer, and hematologic malignancies, as well as considerations for clinical trial designs, treatment of microsatellite instability high solid tumors, and emerging targets in immunotherapy. This report encompasses a selection of information presented at the meeting..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:043 |
|---|---|
| Enthalten in: |
Drugs of the future - 043(2018), 2, Seite 0153 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cole,US!aP. [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| doi: |
10.1358/dof.2018.043.02.2796901 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2000500021 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2000500021 | ||
| 003 | DE-627 | ||
| 005 | 20230516073303.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180809s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1358/dof.2018.043.02.2796901 |2 doi | |
| 028 | 5 | 2 | |a fidpha__2018-08-09.pp |
| 035 | |a (DE-627)OLC2000500021 | ||
| 035 | |a (DE-599)GBVOLC2000500021 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Cole,US!aP. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ASCO-SITC Clinical Immuno-Oncology Symposium. San Francisco, California, USA - January 25-27, 2018 |
| 264 | 1 | |c 2018 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The American Society of Clinical Oncology–Society for Immunotherapy of Cancer (ASCO-SITC) Clinical Immuno-Oncology Symposium focused on clinical and translational research in immuno-oncology and the implications for clinical care. Specifically, speakers discussed immunotherapy in melanoma, lung cancer, genitourinary cancers, head and neck cancer, and hematologic malignancies, as well as considerations for clinical trial designs, treatment of microsatellite instability high solid tumors, and emerging targets in immunotherapy. This report encompasses a selection of information presented at the meeting. | ||
| 700 | 1 | |a Bofill,US!aX. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs of the future |d Barcelona : Prous Science - Thomson Reuters, 1976 |g 043(2018), 2, Seite 0153 |w (DE-627)13048489X |w (DE-600)752959-4 |w (DE-576)016071395 |x 0377-8282 |7 nnns |
| 773 | 1 | 8 | |g volume:043 |g year:2018 |g number:2 |g pages:0153 |
| 856 | 4 | 0 | |u https://doi.org/10.1358/dof.2018.043.02.2796901 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4125 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 043 |j 2018 |e 2 |h 0153 | ||